CRBU
Price
$5.95
Change
+$0.01 (+0.17%)
Updated
Dec 7, 6:59 PM EST
102 days until earnings call
EDIT
Price
$10.90
Change
-$0.21 (-1.89%)
Updated
Dec 7, 6:59 PM EST
77 days until earnings call
Ad is loading...

Compare predictions CRBU vs EDIT

Header iconCRBU vs EDIT Comparison
Open Charts CRBU vs EDITBanner chart's image
Caribou Biosciences
Price$5.95
Change+$0.01 (+0.17%)
Volume$587.3K
CapitalizationN/A
Editas Medicine
Price$10.90
Change-$0.21 (-1.89%)
Volume$1.01M
CapitalizationN/A
View a ticker or compare two or three
CRBU vs EDIT Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
CRBU vs. EDIT commentary
Dec 08, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a StrongBuy and EDIT is a Buy.

COMPARISON
Comparison
Dec 08, 2023
Stock price -- (CRBU: $5.95 vs. EDIT: $10.90)
Brand notoriety: CRBU and EDIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 42% vs. EDIT: 61%
Market capitalization -- CRBU: $508.48M vs. EDIT: $870.23M
CRBU [@Biotechnology] is valued at $508.48M. EDIT’s [@Biotechnology] market capitalization is $870.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileEDIT’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • EDIT’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRBU and EDIT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 6 TA indicator(s) are bullish while EDIT’s TA Score has 5 bullish TA indicator(s).

  • CRBU’s TA Score: 6 bullish, 4 bearish.
  • EDIT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than EDIT.

Price Growth

CRBU (@Biotechnology) experienced а +1.36% price change this week, while EDIT (@Biotechnology) price change was +3.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.23%. For the same industry, the average monthly price growth was +6.91%, and the average quarterly price growth was +25.39%.

Reported Earning Dates

CRBU is expected to report earnings on Mar 18, 2024.

EDIT is expected to report earnings on Feb 22, 2024.

Industries' Descriptions

@Biotechnology (+6.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CRBU with price predictions.
OPEN
A.I.dvisor published
a Summary for EDIT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
EDIT($870M) has a higher market cap than CRBU($508M). EDIT YTD gains are higher at: 22.886 vs. CRBU (-5.255). CRBU has higher annual earnings (EBITDA): -105.9M vs. EDIT (-202.49M). EDIT (350M) and CRBU (338M) have equal amount of cash in the bank . CRBU has less debt than EDIT: CRBU (27.5M) vs EDIT (34.6M). CRBU has higher revenues than EDIT: CRBU (34.6M) vs EDIT (24.6M).
CRBUEDITCRBU / EDIT
Capitalization508M870M58%
EBITDA-105.9M-202.49M52%
Gain YTD-5.25522.886-23%
P/E RatioN/AN/A-
Revenue34.6M24.6M141%
Total Cash338M350M97%
Total Debt27.5M34.6M79%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUEDIT
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bullish Trend 7 days ago
89%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGRCX19.37N/A
N/A
Fidelity Advisor® Mega Cap Stock C
EDICX9.94N/A
N/A
Eaton Vance Global Income Builder C
GUMCX26.18N/A
N/A
Guggenheim Market Neutral Rel Est C
AGWUX50.20N/A
N/A
American Century Growth R5
TVFVX63.41N/A
N/A
Third Avenue Value Investor

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with EDIT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
+0.34%
EDIT - CRBU
51%
Loosely correlated
-1.89%
AXON - CRBU
50%
Loosely correlated
+1.29%
MDGL - CRBU
49%
Loosely correlated
-0.32%
ORMP - CRBU
45%
Loosely correlated
+2.74%
NTLA - CRBU
44%
Loosely correlated
-0.23%
More

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been closely correlated with BEAM. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if EDIT jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
-1.89%
BEAM - EDIT
70%
Closely correlated
+0.28%
NTLA - EDIT
68%
Closely correlated
-0.23%
CRSP - EDIT
65%
Loosely correlated
-1.31%
MDGL - EDIT
61%
Loosely correlated
-0.32%
DNLI - EDIT
59%
Loosely correlated
-2.09%
More